Dizal Licenses Zegfrovy to AstraZeneca in $1.5B Deal
SHANGHAI, China, July 14, 2026 Dizal has entered into a landmark global exclusive license agreement with AstraZeneca for Zegfrovy...
Global Licensing Agreement
Advertisement
Teva Expands Global Biosimilar Portfolio With Polpharma
TEL AVIV, Israel / ZUG, Switzerland | July 9, 2026 Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical...
Organon Completes Global MIUDELLA® Licensing Agreement
JERSEY CITY, N.J., June 22, 2026 Organon has completed a global licensing agreement with Sebela Pharmaceuticals for MIUDELLA®, a...
Lilly’s Retevmo Cuts Recurrence Risk by 83% in NSCLC
INDIANAPOLIS, Indiana, May 31, 2026 Eli Lilly and Company has announced groundbreaking results from the pivotal Phase 3 LIBRETTO-432...
Hanmi and Lilly Strike $1.26 Billion Deal for Promising GLP-2 Drug Candidate Sonefpeglutide
SEOUL, South Korea, June 1, 2026 Hanmi Pharm. Co., Ltd. has entered into a landmark global licensing agreement with...
Advertisement
